Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
SELLAS Life Sciences Group is a US-based biopharmaceutical company specializing in the development of innovative cancer therapies. It focuses on novel immuno-oncology agents for the treatment of various types of tumors, with the ultimate goal of improving patient care and outcomes.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
SELLAS Life Sciences Group is scheduled to report its next quarterly earnings on 11/18/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
SELLAS Life Sciences Group last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.05 USD.
Across its last 3 earnings reports, SELLAS Life Sciences Group stock moved by ±13.4% on average the following day. The largest reaction was +25.1% on 05/12/2026; 2 of 3 reactions were positive.
SELLAS Life Sciences Group has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.